News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Elan Corporation PLC (ELN) Says Tysabri Brain Disease Link Uncertain


8/28/2008 7:17:05 AM

LONDON (SHARECAST) - Irish drug giant Elan said the risk of a fatal brain disease in patients treated with its multiple sclerosis drug Tysabri “cannot be precisely estimated.” The group made the comments as it saw losses narrow for the half year on strong sales of the MS drug.

Read at Share Cast


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES